Kymera Therapeutics (NASDAQ: KYMR)
Kymera Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Kymera Therapeutics Company Info
Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.
News & Analysis
Why Kymera Therapeutics Stock Crushed it This Week
Why Kymera Therapeutics Stock Is Soaring Today
Kymera's lead pipeline candidate received some good news.
Why Shares of Kymera Therapeutics Jumped on Tuesday
The company had a big bounce after hitting a 52-week low the day before.
These Biotech Stocks Are the Nasdaq's Big Wednesday Winners
Business wins are shining the spotlight on these two companies.
Why Kymera Therapeutics Stock Is Getting Hammered Today
The biotech upset investors today with disappointing news for its lead program.
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
Is it time to buy a basket of biotech stocks?
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.